← Back to Intel
Insider ActivityPRLD
Morris Charles Q, Chief Medical Officer at Prelude Therapeutics Inc, traded $2.1M of PRLD
Updated Jun 21, 2026
Morris Charles Q
Chief Medical Officer
Prelude Therapeutics Inc ·
$PRLD
Transaction Details
| Insider | Morris Charles Q |
|---|---|
| Title | Chief Medical Officer |
| Company | Prelude Therapeutics Inc |
| Ticker | PRLD |
| Transaction Type | Grant |
| Transaction Date | 2026-05-01 |
| Shares Traded | 450,000 |
| Price Per Share | $4.7 |
| Total Value | $2.1M |
| Filed Date | 2026-05-04 |
| Accession Number | 0001489966-26-000004 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001489966-26-000004
Other Insider Trades — PRLD
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Sandor Victor | Insider | traded | — | 2026-06-09 |
| BAKER BROS. ADVISORS LP | Insider | traded | — | 2026-06-09 |
| FRIEDMAN PAUL A | Insider | traded | — | 2026-06-09 |
| Bonita David P | Insider | traded | — | 2026-06-09 |
| Dorton Katina | Insider | traded | — | 2026-06-09 |
| Babler Martin | Insider | traded | — | 2026-06-09 |
| RA CAPITAL MANAGEMENT, L.P. | Insider | traded | — | 2026-04-27 |
| BAKER BROS. ADVISORS LP | Insider | bought | $509K | 2026-04-21 |
| Bonita David P | Director, 10% Owner | bought | $5.0M | 2026-04-21 |
| Bonita David P | Director, 10% Owner | bought | $7.5M | 2026-04-21 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for PRLD — Prelude Therapeutics Inc →
Track PRLD insider activity in real time on The Wire →
Get alerts when Morris Charles Q files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 21, 2026 at 07:18 UTC